These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21380606)

  • 21. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites.
    Strano-Rossi S; Colamonici C; Botrè F
    Rapid Commun Mass Spectrom; 2007; 21(2):79-88. PubMed ID: 17154357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A steroidomic approach for biomarkers discovery in doping control.
    Boccard J; Badoud F; Grata E; Ouertani S; Hanafi M; Mazerolles G; Lantéri P; Veuthey JL; Saugy M; Rudaz S
    Forensic Sci Int; 2011 Dec; 213(1-3):85-94. PubMed ID: 21831550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous identification of prednisolone and its ten metabolites in human urine by high performance liquid chromatography-tandem mass spectrometry.
    Ahi S; Beotra A; Dubey S; Upadhyay A; Jain S
    Drug Test Anal; 2012 Jun; 4(6):460-7. PubMed ID: 22354815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
    Sobolevsky T; Rodchenkov G
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose.
    Wójtowicz M; Jarek A; Chajewska K; Turek-Lepa E; Kwiatkowska D
    J Pharm Biomed Anal; 2015 Nov; 115():523-33. PubMed ID: 26311473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-drug interaction and doping, part 1: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of toremifene.
    Mazzarino M; de la Torre X; Fiacco I; Palermo A; Botrè F
    Drug Test Anal; 2014 May; 6(5):482-91. PubMed ID: 24431005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing.
    Solymos E; Guddat S; Geyer H; Flenker U; Thomas A; Segura J; Ventura R; Platen P; Schulte-Mattler M; Thevis M; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):517-28. PubMed ID: 21188579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new sulphate metabolite as a long-term marker of metandienone misuse.
    Gómez C; Pozo OJ; Garrostas L; Segura J; Ventura R
    Steroids; 2013 Dec; 78(12-13):1245-53. PubMed ID: 24055830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary metabolic profile of 19-norsteroids in humans: glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol.
    Torrado S; Roig M; Farré M; Segura J; Ventura R
    Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3035-42. PubMed ID: 18763272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New potential biomarkers for mesterolone misuse in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry.
    Lu J; Fernández-Álvarez M; Yang S; He G; Xu Y; Aguilera R
    J Mass Spectrom; 2015 Jan; 50(1):153-9. PubMed ID: 25601687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultra high performance liquid chromatography tandem mass spectrometric detection of glucuronides resistant to enzymatic hydrolysis: Implications to doping control analysis.
    Kotronoulas A; Marcos J; Segura J; Ventura R; Joglar J; Pozo OJ
    Anal Chim Acta; 2015 Oct; 895():35-44. PubMed ID: 26454457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry.
    Touber ME; van Engelen MC; Georgakopoulus C; van Rhijn JA; Nielen MW
    Anal Chim Acta; 2007 Mar; 586(1-2):137-46. PubMed ID: 17386705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
    Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
    Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.
    Beuck S; Möller I; Thomas A; Klose A; Schlörer N; Schänzer W; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):493-505. PubMed ID: 21455647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-MS/MS detection of unaltered glucuronoconjugated metabolites of metandienone.
    Esquivel A; Pozo OJ; Garrostas L; Balcells G; Gómez C; Kotronoulas A; Joglar J; Ventura R
    Drug Test Anal; 2017 Apr; 9(4):534-544. PubMed ID: 27237125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New potential markers for the detection of boldenone misuse.
    Gómez C; Pozo OJ; Geyer H; Marcos J; Thevis M; Schänzer W; Segura J; Ventura R
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):239-46. PubMed ID: 22664392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing.
    Dib J; Schlörer N; Schänzer W; Thevis M
    J Mass Spectrom; 2015 Feb; 50(2):407-17. PubMed ID: 25800023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose.
    Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D
    Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometric detection of peginesatide in human urine in doping control analysis.
    Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.